Mesenchymal Stem Cells for Regenerative Medicine

Mesenchymal stem cells (MSCs) were highlighted for their potential in regenerative medicine due to their ability to differentiate into various cell types and their low risk of immune rejection. MSCs could be extracted from sources like bone marrow, fat, and synovium, making them versatile for biomedical applications. Their lack of significant histocompatibility complexes allowed them to evade immune detection, reducing the risk of graft rejection. The document provided an overview of MSC extraction and differentiation, as well as their preclinical and clinical applications, while also addressing future challenges in the field.